Clinical Out Come with Single Dose Ondansetron versus Domperidone in Paediatric Gastroenteritis – Our Experience
Journal Title: Journal of Medical Science And clinical Research - Year 2015, Vol 3, Issue 6
Abstract
Background: Acute gastroenteritis (AGE) is a diarrheal disease of rapid onset, with or without accompanying symptoms and signs, such as nausea, vomiting, fever, or abdominal pain. The WHO recommends ORS as the treatment of choice for children with mild to moderate gastroenteritis in both developed and developing countries. Vomiting limits the success of oral rehydration in children with gastroenteritis. Ondansetron has been proven safe and effective in chemotherapy induced and post operative vomiting. It is a selective serotonin 5HT-3 receptor blocker and inhibits the initiation of the vomiting reflex in the periphery. We have evaluated single dose of ondansetron versus domperidone on clinical outcome in paediatric gastroenteritis. Methods: It is an open-label randomized study was undertaken at department of Pediatrics, Narayana Medical College, Nellore for a period of six months. A total 84 children, age group between 3- 10 years of age were selected for the study. The patients were randomly assigned to receive Ondonsetron or Domperidone and were stratified according to the dose of medication. The bedside nurse or care giver is instructed to administer the medication. Vomiting episodes were tabulated in 24 hrs starting from the time of drug administration until cessation of vomiting. The primary outcomes recorded were the need and duration for oral / intravenous rehydration and hospitalization. Data was presented as Mean, SD, Range, actual numbers and Percentages. Statistical analysis was carried by using paired t test. Results: Out of 84 children in each group whose data were analyzed, 42 patients received ondansetron and remaining 42 received domperidone along with oral-rehydration therapy. As compared with children who received domperidone, children who received ondansetron were less likely to vomit (12 percent vs. 37 percent; relative risk, 0.44; 80 percent confidence interval with P<0.001) Conclusion: In children with acute gastroenteritis with vomiting, a single dose of ondansetron reduces vomiting and well tolerated with oral rehydration therapy compared to domperidone
Authors and Affiliations
SK Salma Kamal
Keywords
Related Articles
- EP ID EP211691
- DOI -
- Views 90
- Downloads 0
Randomized Study of Medical Line of Treatment and Surgical Line of Treatment in the Management of Benign Prostatic Hyperplasia in A Tertiary Care Centre
Objectives 1. To study BPH, in relation to uroflowmetry after medical line of management and surgical line of management. 2. To study the outcome of both the line of management. Methods: Between December 2014 to July 201...
Adenomatoid Tumour of the Uterus: A Rare Case Report
Adenomatoid tumours are rare benign tumours originating in the mesothelium. Uterine adenomatoid tumours are benign tumours of the uterine serosa and myometrium that originate from the mesothelium. They are mostly under d...
Study of Retinopathy of Prematurity in a Tertiary Care Hospital
OBJECTIVES 1. To study the incidence of Retinopathy of Prematurity (ROP) in a tertiary care hospital, in a metropolitan city. 2. To study associated etiological risk factors for development of Retinopathy of Prematurity....
To study common cause of UTI in Female patients coming to Hospital with Special focus to restrain Antibiotic resistance
Urinary tract infections (UTIs) are conditions frequently complained by women both in the general population and in the hospital setting. Indeed it has been estimated that one woman out of three will experience at least...
Comparison of Intra-Operative ECG Variations (QRS and PR Interval Prolongation) Between 0.25% Ropivacaine and 0.25% Bupivacaine in Patients Undergoing Lower Limb Surgery under Epidural Blockade
Background: Ropivacaine, new aminoamide local anaesthetic (LA) drug, is chemically homologous to bupivacaine. The lower lipid solubility and higher clearance of ropivacaine compared with bupivacaine is presumed to retard...